Literature DB >> 25755696

FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells.

Lu Zheng1, Bo Qian1, Duo Tian1, Tong Tang1, Shengyun Wan1, Lei Wang1, Lixin Zhu2, Xiaoping Geng1.   

Abstract

OBJECTIVE: DNA methylation is an important epigenetic modification with tumor suppressor gene silencing in cancer. The mechanisms underlying DNA methylation patterns are still poorly understood. This study aims to evaluate the potential value of FOXA1 for controlling gene CpG island methylation in breast cancer.
METHODS: FOXA1 was down-regulated by transfection with siRNA and up-regulated by transfection with plasmid in MCF-7 cell lines. The DNA methylation and mRNA levels were examined by qMSP and qRT-PCR. The cell proliferation and apoptosis was detected by MTT and Flow cytometry.
RESULTS: Suppression of FOXA1 enhanced the methylation status of DAPK, MGMT, RASSF1A, p53, and depressed mRNA levels of these tumor suppressor genes, whereas over-expression of FOXA1 showed the opposite effects. DNMT1, DNMT3A and DNMT3B mRNA were up-regulated by siRNA knock-down of FOXA1. At the same time, FOXA1 suppression promoted cell growth and inhibited apoptosis.
CONCLUSIONS: FOXA1 may be associated with methylation of the tumor suppressor genes promoter through changing DNMTs expression. FOXA1 could be a potential demethylation target for prevention and treatment of breast cancer.

Entities:  

Keywords:  FOXA1; MCF-7; methylation; tumor suppressor gene expression

Mesh:

Substances:

Year:  2015        PMID: 25755696      PMCID: PMC4348911     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  47 in total

Review 1.  DNA methylation and silencing of gene expression.

Authors:  J Newell-Price; A J Clark; P King
Journal:  Trends Endocrinol Metab       Date:  2000 May-Jun       Impact factor: 12.015

Review 2.  Altered DNA methylation: a secondary mechanism involved in carcinogenesis.

Authors:  Jay I Goodman; Rebecca E Watson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

3.  Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4.

Authors:  Lisa Ann Cirillo; Frank Robert Lin; Isabel Cuesta; Dara Friedman; Michal Jarnik; Kenneth S Zaret
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

4.  Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis.

Authors:  M D Vos; C A Ellis; A Bell; M J Birrer; G J Clark
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

5.  SnapShot: forkhead transcription factors I.

Authors:  Geetu Tuteja; Klaus H Kaestner
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

6.  Forkhead transcription factors II.

Authors:  Geetu Tuteja; Klaus H Kaestner
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

7.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

Review 8.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

9.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.

Authors:  Ewan Birney; John A Stamatoyannopoulos; Anindya Dutta; Roderic Guigó; Thomas R Gingeras; Elliott H Margulies; Zhiping Weng; Michael Snyder; Emmanouil T Dermitzakis; Robert E Thurman; Michael S Kuehn; Christopher M Taylor; Shane Neph; Christoph M Koch; Saurabh Asthana; Ankit Malhotra; Ivan Adzhubei; Jason A Greenbaum; Robert M Andrews; Paul Flicek; Patrick J Boyle; Hua Cao; Nigel P Carter; Gayle K Clelland; Sean Davis; Nathan Day; Pawandeep Dhami; Shane C Dillon; Michael O Dorschner; Heike Fiegler; Paul G Giresi; Jeff Goldy; Michael Hawrylycz; Andrew Haydock; Richard Humbert; Keith D James; Brett E Johnson; Ericka M Johnson; Tristan T Frum; Elizabeth R Rosenzweig; Neerja Karnani; Kirsten Lee; Gregory C Lefebvre; Patrick A Navas; Fidencio Neri; Stephen C J Parker; Peter J Sabo; Richard Sandstrom; Anthony Shafer; David Vetrie; Molly Weaver; Sarah Wilcox; Man Yu; Francis S Collins; Job Dekker; Jason D Lieb; Thomas D Tullius; Gregory E Crawford; Shamil Sunyaev; William S Noble; Ian Dunham; France Denoeud; Alexandre Reymond; Philipp Kapranov; Joel Rozowsky; Deyou Zheng; Robert Castelo; Adam Frankish; Jennifer Harrow; Srinka Ghosh; Albin Sandelin; Ivo L Hofacker; Robert Baertsch; Damian Keefe; Sujit Dike; Jill Cheng; Heather A Hirsch; Edward A Sekinger; Julien Lagarde; Josep F Abril; Atif Shahab; Christoph Flamm; Claudia Fried; Jörg Hackermüller; Jana Hertel; Manja Lindemeyer; Kristin Missal; Andrea Tanzer; Stefan Washietl; Jan Korbel; Olof Emanuelsson; Jakob S Pedersen; Nancy Holroyd; Ruth Taylor; David Swarbreck; Nicholas Matthews; Mark C Dickson; Daryl J Thomas; Matthew T Weirauch; James Gilbert; Jorg Drenkow; Ian Bell; XiaoDong Zhao; K G Srinivasan; Wing-Kin Sung; Hong Sain Ooi; Kuo Ping Chiu; Sylvain Foissac; Tyler Alioto; Michael Brent; Lior Pachter; Michael L Tress; Alfonso Valencia; Siew Woh Choo; Chiou Yu Choo; Catherine Ucla; Caroline Manzano; Carine Wyss; Evelyn Cheung; Taane G Clark; James B Brown; Madhavan Ganesh; Sandeep Patel; Hari Tammana; Jacqueline Chrast; Charlotte N Henrichsen; Chikatoshi Kai; Jun Kawai; Ugrappa Nagalakshmi; Jiaqian Wu; Zheng Lian; Jin Lian; Peter Newburger; Xueqing Zhang; Peter Bickel; John S Mattick; Piero Carninci; Yoshihide Hayashizaki; Sherman Weissman; Tim Hubbard; Richard M Myers; Jane Rogers; Peter F Stadler; Todd M Lowe; Chia-Lin Wei; Yijun Ruan; Kevin Struhl; Mark Gerstein; Stylianos E Antonarakis; Yutao Fu; Eric D Green; Ulaş Karaöz; Adam Siepel; James Taylor; Laura A Liefer; Kris A Wetterstrand; Peter J Good; Elise A Feingold; Mark S Guyer; Gregory M Cooper; George Asimenos; Colin N Dewey; Minmei Hou; Sergey Nikolaev; Juan I Montoya-Burgos; Ari Löytynoja; Simon Whelan; Fabio Pardi; Tim Massingham; Haiyan Huang; Nancy R Zhang; Ian Holmes; James C Mullikin; Abel Ureta-Vidal; Benedict Paten; Michael Seringhaus; Deanna Church; Kate Rosenbloom; W James Kent; Eric A Stone; Serafim Batzoglou; Nick Goldman; Ross C Hardison; David Haussler; Webb Miller; Arend Sidow; Nathan D Trinklein; Zhengdong D Zhang; Leah Barrera; Rhona Stuart; David C King; Adam Ameur; Stefan Enroth; Mark C Bieda; Jonghwan Kim; Akshay A Bhinge; Nan Jiang; Jun Liu; Fei Yao; Vinsensius B Vega; Charlie W H Lee; Patrick Ng; Atif Shahab; Annie Yang; Zarmik Moqtaderi; Zhou Zhu; Xiaoqin Xu; Sharon Squazzo; Matthew J Oberley; David Inman; Michael A Singer; Todd A Richmond; Kyle J Munn; Alvaro Rada-Iglesias; Ola Wallerman; Jan Komorowski; Joanna C Fowler; Phillippe Couttet; Alexander W Bruce; Oliver M Dovey; Peter D Ellis; Cordelia F Langford; David A Nix; Ghia Euskirchen; Stephen Hartman; Alexander E Urban; Peter Kraus; Sara Van Calcar; Nate Heintzman; Tae Hoon Kim; Kun Wang; Chunxu Qu; Gary Hon; Rosa Luna; Christopher K Glass; M Geoff Rosenfeld; Shelley Force Aldred; Sara J Cooper; Anason Halees; Jane M Lin; Hennady P Shulha; Xiaoling Zhang; Mousheng Xu; Jaafar N S Haidar; Yong Yu; Yijun Ruan; Vishwanath R Iyer; Roland D Green; Claes Wadelius; Peggy J Farnham; Bing Ren; Rachel A Harte; Angie S Hinrichs; Heather Trumbower; Hiram Clawson; Jennifer Hillman-Jackson; Ann S Zweig; Kayla Smith; Archana Thakkapallayil; Galt Barber; Robert M Kuhn; Donna Karolchik; Lluis Armengol; Christine P Bird; Paul I W de Bakker; Andrew D Kern; Nuria Lopez-Bigas; Joel D Martin; Barbara E Stranger; Abigail Woodroffe; Eugene Davydov; Antigone Dimas; Eduardo Eyras; Ingileif B Hallgrímsdóttir; Julian Huppert; Michael C Zody; Gonçalo R Abecasis; Xavier Estivill; Gerard G Bouffard; Xiaobin Guan; Nancy F Hansen; Jacquelyn R Idol; Valerie V B Maduro; Baishali Maskeri; Jennifer C McDowell; Morgan Park; Pamela J Thomas; Alice C Young; Robert W Blakesley; Donna M Muzny; Erica Sodergren; David A Wheeler; Kim C Worley; Huaiyang Jiang; George M Weinstock; Richard A Gibbs; Tina Graves; Robert Fulton; Elaine R Mardis; Richard K Wilson; Michele Clamp; James Cuff; Sante Gnerre; David B Jaffe; Jean L Chang; Kerstin Lindblad-Toh; Eric S Lander; Maxim Koriabine; Mikhail Nefedov; Kazutoyo Osoegawa; Yuko Yoshinaga; Baoli Zhu; Pieter J de Jong
Journal:  Nature       Date:  2007-06-14       Impact factor: 49.962

10.  Correlation between CpG methylation profiles and hormone receptor status in breast cancers.

Authors:  Weiwei Feng; Lanlan Shen; Sijin Wen; Daniel G Rosen; Jaroslav Jelinek; Xin Hu; Shaoyi Huan; Miao Huang; Jinsong Liu; Aysegul A Sahin; Kelly K Hunt; Robert C Bast; Yu Shen; Jean-Pierre J Issa; Yinhua Yu
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  9 in total

1.  Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma.

Authors:  Zhongwei Jia; Fangning Wan; Yao Zhu; Guohai Shi; Hailiang Zhang; Bo Dai; Dingwei Ye
Journal:  Oncol Lett       Date:  2018-04-02       Impact factor: 2.967

2.  MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1.

Authors:  Jian Liu; Bohua Chen; Bin Yue; Junde Yang
Journal:  Exp Ther Med       Date:  2016-11-07       Impact factor: 2.447

3.  Time-varying effects of FOXA1 on breast cancer prognosis.

Authors:  Qian-Xin Chen; Yuan-Zhong Yang; Zhuo-Zhi Liang; Jia-Li Chen; Yue-Lin Li; Zi-Yi Huang; Zi-Jin Weng; Xiao-Fang Zhang; Jie-Xia Guan; Lu-Ying Tang; Jing-Ping Yun; Ze-Fang Ren
Journal:  Breast Cancer Res Treat       Date:  2021-02-18       Impact factor: 4.872

4.  Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers.

Authors:  Xiaofeng Dai; Yang Li; Zhonghu Bai; Xu-Qing Tang
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

5.  Progression inference for somatic mutations in cancer.

Authors:  Leif E Peterson; Tatiana Kovyrshina
Journal:  Heliyon       Date:  2017-04-11

6.  Integrative Transcriptome-Wide Analyses Uncover Novel Risk-Associated MicroRNAs in Hormone-Dependent Cancers.

Authors:  Dulari K Jayarathna; Miguel E Rentería; Adil Malik; Emilie Sauret; Jyotsna Batra; Neha S Gandhi
Journal:  Front Genet       Date:  2021-08-26       Impact factor: 4.599

7.  Elevated FOXA1 Expression Indicates Poor Prognosis in Liver Cancer due to Its Effects on Cell Proliferation and Metastasis.

Authors:  Zhenrong Liu; Yaru Wang; Zulihumaer Aizimuaji; Sheng Ma; Ting Xiao
Journal:  Dis Markers       Date:  2022-08-05       Impact factor: 3.464

8.  FOXA1 regulates alternative splicing in prostate cancer.

Authors:  Marco Del Giudice; John G Foster; Serena Peirone; Alberto Rissone; Livia Caizzi; Federica Gaudino; Caterina Parlato; Francesca Anselmi; Rebecca Arkell; Simonetta Guarrera; Salvatore Oliviero; Giuseppe Basso; Prabhakar Rajan; Matteo Cereda
Journal:  Cell Rep       Date:  2022-09-27       Impact factor: 9.995

9.  High FOXA1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer.

Authors:  Heba Sheta; Amal Abd El Hafez; Maha Saif; Alyaa R Elsergany; Doaa Al Emam; Mahmoud Mohamed Abdelrazik
Journal:  Pathologica       Date:  2021-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.